TORONTO, ONTARIO--(Marketwired - Apr 25, 2014) - Vida Cannabis Corp. ("Vida Cannabis") is pleased to announce the appointment of Derek Ogden to the position of Chief Operating Officer as well as Responsible Person in Charge of its wholly owned subsidiary, Vida Cannabis (Canada) Ltd. ("Vida Canada"). As the Responsible Person in Charge (RPIC), Mr. Ogden will work at the site and will be responsible for supervising all licensed activities, and for ensuring that the activities comply with the CDSA, its regulations and the Food and Drugs Act.
Derek Ogden spent nearly 27 years with the RCMP, rising to the rank of Chief Superintendent. He served as Officer in Charge of Drug Enforcement and as Director General of the Drugs and Organized Crime branch, where he oversaw the national drug enforcement program, organized crime investigations, national undercover program, source witness protection program and source development, and headed up approximately 1300 investigators. His tenure with RCMP began as a police officer from 1981 to 2000 in British Columbia. Over the course of his career, Mr. Ogden has worked closely with Health Canada as well as the Departments of Defense and Justice.
Most recently, Mr. Ogden served as president of Obsidian Consulting & Investigations, which serves global clients to investigate counterfeit medical devices and protect intellectual property for government and corporate clients. Previously, after retiring from the RCMP he became Director of the Anti-Illicit Trade Program and Director of Security for the largest tobacco company in Canada. Derek has significant experience in all aspects of security pertaining to employees, physical assets and company product.
Derek Ogden earned his Bachelor of Business Administration from the University of New Brunswick and completed the Executive Management Program at Queen's University. He is fluent in both French and English.
Vida Cannabis CEO Greg Wilson stated: "Derek Ogden brings an unsurpassed level of skills and experience, in both the public and private sectors, to Vida Cannabis Corp. and I am delighted to welcome him to the team. Derek's input as we finalize our licensed producer application for Health Canada and implement Level 10 security measures at our facility in Stellarton are invaluable and particularly timely. I feel extremely confident about the continuing growth of Vida Cannabis Corp. and the value we bring to shareholders as well as to our future customers."
In accepting the appointment, Mr. Ogden stated: "I look forward to continuing to move forward the rapid growth of Vida Cannabis Corp. begun by the company's current executive leadership. Excellent progress has already been made in a very short period in developing the physical property in Stellarton, Nova Scotia, as well as preparing the Health Canada licensure application. The experience of the experts at Quantum 9 consulting specific to the marijuana industry is a valuable adjunct to my own law enforcement, security, illicit trade mitigation and investigatory experience. This is an exciting team and I anticipate being able to announce extremely positive developments quite soon as Vida Cannabis grows to become Canada's dominant medical marijuana producer."
About Vida Cannabis Corp.
Vida Cannabis Corp. ("Vida Cannabis") is focused on developing a dominant production footprint in the rapidly developing global marketplace for the legal use of medicinal and recreational marijuana.
Initial operations are focused on the Canadian market where Health Canada has established national guidelines enabling best-in-class producers to acquire commercial production licenses under the Marihuana for Medical Purposes Regulations.
Via its wholly owned subsidiary, Vida Cannabis (Canada) Ltd., Vida Cannabis purchased a 315,000-square-foot production facility in the town of Stellarton, NS and secured a 50-year irrevocable approval unanimously from the local municipality to operate a medical marijuana production plant at the facility.
The highly secure facility boasts a fully engineered concrete floor, 18-foot-high concrete walls and a steel roof making it an ideal location for the construction of a customized, state-of-the-art modern medical marijuana production plant.
Vida Cannabis is working with one of the most talented cannabis consulting teams in the world, Quantum 9 Inc., which has extensive resources in the United States, Canada and Europe, to establish an optimized end-to-end production plan to help position Vida Cannabis with the largest, most advanced medical marijuana facility in Canada.
Vida Cannabis continues to evaluate additional potential markets as regulatory bodies around the world pass legislation enabling the production and distribution of medicinal or recreational marijuana.
On behalf of the board,
Greg Wilson, Director & CEO
Vida Cannabis Corp.
This announcement does not constitute or form part of, and shall under no circumstances be considered as, an offer to sell, a solicitation to purchase, or advice on investments in any securities of Vida Cannabis Corp. ("Vida Cannabis"). Offers and solicitations shall be expressly identified as such and made in compliance with applicable securities laws. This announcement is for information purposes only. It should not be relied upon as a basis for investment decisions. You should consult with your own investment, accounting, legal and tax advisers to evaluate independently the risks, consequences and suitability of any investments you are considering. Whilst the information provided here is believed to be reliable, it cannot be guaranteed. It may contain forward-looking statements made by or on behalf of Vida Cannabis about its business or financial objectives, position, strategies or expectations. Such forward-looking statements may be identified by words such as, or similar to, "intends," "anticipates," "believes," "expects" and "hopes" and includes, without limitation, the development of production facilities, approval from regulatory authorities and the ability for Vida Cannabis to obtain adequate financing to meet its business objectives. These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. The statements in this announcement do not guarantee future performance. Vida Cannabis does not undertake any obligation to update any information provided in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned subsidiary of Vida Cannabis, must obtain approval from Health Canada in order to operate as a licensed commercial producer under the Marihuana for Medical Purposes Regulations. Vida Cannabis makes no representations or warranties that it will receive Health Canada approval.